121 related articles for article (PubMed ID: 38230602)
21. The effect of catheter-based sham renal denervation in hypertension: systematic review and meta-analysis.
Fernandes A; David C; Pinto FJ; Costa J; Ferreira JJ; Caldeira D
BMC Cardiovasc Disord; 2023 May; 23(1):249. PubMed ID: 37173636
[TBL] [Abstract][Full Text] [Related]
22. Renal denervation for resistant hypertension.
Coppolino G; Pisano A; Rivoli L; Bolignano D
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD011499. PubMed ID: 28220472
[TBL] [Abstract][Full Text] [Related]
23. Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial.
Kario K; Mahfoud F; Kandzari DE; Townsend RR; Weber MA; Schmieder RE; Tsioufis K; Pocock S; Brar S; Hettrick DA; Fahy M; Böhm M
Hypertens Res; 2023 Jan; 46(1):280-288. PubMed ID: 36241705
[TBL] [Abstract][Full Text] [Related]
24. Twenty-Four-Hour Pulsatile Hemodynamics Predict Brachial Blood Pressure Response to Renal Denervation in the SPYRAL HTN-OFF MED Trial.
Weber T; Wassertheurer S; Mayer CC; Hametner B; Danninger K; Townsend RR; Mahfoud F; Kario K; Fahy M; DeBruin V; Peterson N; Negoita M; Weber MA; Kandzari DE; Schmieder RE; Tsioufis KP; Binder RK; Böhm M
Hypertension; 2022 Jul; 79(7):1506-1514. PubMed ID: 35582957
[TBL] [Abstract][Full Text] [Related]
25. Feasibility of catheter ablation renal denervation in "mild" resistant hypertension.
Chen S; Kiuchi MG; Acou WJ; Derndorfer M; Wang J; Li R; Kollias G; Martinek M; Kiuchi T; Pürerfellner H; Liu S
J Clin Hypertens (Greenwich); 2017 Apr; 19(4):361-368. PubMed ID: 28266770
[TBL] [Abstract][Full Text] [Related]
26. The effect of renal sympathetic denervation on nocturnal dipping in patients with resistant hypertension; observational data from a tertiary referral centre in the Republic of Ireland.
Tuohy ST; Kyvelou SG; Gleeson PJ; Daniels FB; Ryan LA; Lappin DW; O'Donnell MJ; Sharif F
Ir J Med Sci; 2016 Aug; 185(3):635-641. PubMed ID: 26089291
[TBL] [Abstract][Full Text] [Related]
27. Long-term follow-up of patients undergoing renal sympathetic denervation.
Zeijen VJM; Feyz L; Nannan Panday R; Veen K; Versmissen J; Kardys I; Van Mieghem NM; Daemen J
Clin Res Cardiol; 2022 Nov; 111(11):1256-1268. PubMed ID: 35851428
[TBL] [Abstract][Full Text] [Related]
28. Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications.
Kandzari DE; Townsend RR; Kario K; Mahfoud F; Weber MA; Schmieder RE; Pocock S; Tsioufis K; Konstantinidis D; Choi J; East C; Lauder L; Cohen DL; Kobayashi T; Schmid A; Lee DP; Ma A; Weil J; Agdirlioglu T; Schlaich MP; Shetty S; Devireddy CM; Lea J; Aoki J; Sharp ASP; Anderson R; Fahy M; DeBruin V; Brar S; Böhm M;
J Am Coll Cardiol; 2023 Nov; 82(19):1809-1823. PubMed ID: 37914510
[TBL] [Abstract][Full Text] [Related]
29. Effects of renal sympathetic denervation on heart rate and atrioventricular conduction in patients with resistant hypertension.
Ukena C; Mahfoud F; Spies A; Kindermann I; Linz D; Cremers B; Laufs U; Neuberger HR; Böhm M
Int J Cardiol; 2013 Sep; 167(6):2846-51. PubMed ID: 22917547
[TBL] [Abstract][Full Text] [Related]
30. Effect of renal denervation in attenuating the stress of morning surge in blood pressure: post-hoc analysis from the SPYRAL HTN-ON MED trial.
Kario K; Weber MA; Böhm M; Townsend RR; Mahfoud F; Schmieder RE; Tsioufis K; Cohen SA; Fahy M; Kandzari DE
Clin Res Cardiol; 2021 May; 110(5):725-731. PubMed ID: 32740754
[TBL] [Abstract][Full Text] [Related]
31. Vascular and renal hemodynamic changes after renal denervation.
Ott C; Janka R; Schmid A; Titze S; Ditting T; Sobotka PA; Veelken R; Uder M; Schmieder RE
Clin J Am Soc Nephrol; 2013 Jul; 8(7):1195-201. PubMed ID: 23559677
[TBL] [Abstract][Full Text] [Related]
32. Renal nerve stimulation: complete versus incomplete renal sympathetic denervation.
Hoogerwaard AF; Adiyaman A; de Jong MR; Smit JJ; Heeg JE; van Hasselt BAAM; Elvan A
Blood Press; 2021 Dec; 30(6):376-385. PubMed ID: 34647513
[TBL] [Abstract][Full Text] [Related]
33. Dipping Status, Ambulatory Blood Pressure Control, Cardiovascular Disease, and Kidney Disease Progression: A Multicenter Cohort Study of CKD.
Borrelli S; Garofalo C; Gabbai FB; Chiodini P; Signoriello S; Paoletti E; Ravera M; Bussalino E; Bellizzi V; Liberti ME; De Nicola L; Minutolo R
Am J Kidney Dis; 2023 Jan; 81(1):15-24.e1. PubMed ID: 35709922
[TBL] [Abstract][Full Text] [Related]
34. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.
Donazzan L; Mahfoud F; Ewen S; Ukena C; Cremers B; Kirsch CM; Hellwig D; Eweiwi T; Ezziddin S; Esler M; Böhm M
Clin Res Cardiol; 2016 Apr; 105(4):364-71. PubMed ID: 26493305
[TBL] [Abstract][Full Text] [Related]
35. Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry.
Vogel B; Kirchberger M; Zeier M; Stoll F; Meder B; Saure D; Andrassy M; Mueller OJ; Hardt S; Schwenger V; Strothmeyer A; Katus HA; Blessing E
Clin Res Cardiol; 2014 Feb; 103(2):117-24. PubMed ID: 24126436
[TBL] [Abstract][Full Text] [Related]
36. Anatomical and procedural determinants of ambulatory blood pressure lowering following catheter-based renal denervation using radiofrequency.
Lauder L; Ewen S; Tzafriri AR; Edelman ER; Cremers B; Kulenthiran S; Ukena C; Linz D; Kindermann I; Tsioufis C; Scheller B; Böhm M; Mahfoud F
Cardiovasc Revasc Med; 2018; 19(7 Pt B):845-851. PubMed ID: 29555535
[TBL] [Abstract][Full Text] [Related]
37. Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry.
Mahfoud F; Böhm M; Schmieder R; Narkiewicz K; Ewen S; Ruilope L; Schlaich M; Williams B; Fahy M; Mancia G
Eur Heart J; 2019 Nov; 40(42):3474-3482. PubMed ID: 30907413
[TBL] [Abstract][Full Text] [Related]
38. Influence of pseudo-resistance on the effect of renal denervation on 24-hour ambulatory blood pressure levels.
Lambert T; Nahler A; Reiter C; Gammer V; Blessberger H; Kammler J; Grund M; Saleh K; Schwarz S; Steinwender C
Catheter Cardiovasc Interv; 2015 Sep; 86(3):E126-30. PubMed ID: 26033366
[TBL] [Abstract][Full Text] [Related]
39. Resistant hypertension: Renal denervation or pharmacovigilance? Insights from a renal denervation screening program.
Ojrzanowski M; Kasprzak JD; Peruga JZ; Kurpesa M; Jankowski Ł; Sahni S; Plewka M
Adv Clin Exp Med; 2019 Nov; 28(11):1525-1530. PubMed ID: 31693316
[TBL] [Abstract][Full Text] [Related]
40. Effects of renal denervation on end organ damage in hypertensive patients.
Verloop WL; Vink EE; Spiering W; Blankestijn PJ; Doevendans PA; Bots ML; Vonken EJ; Voskuil M; Leiner T
Eur J Prev Cardiol; 2015 May; 22(5):558-67. PubMed ID: 25326543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
